Jago Times "English Edition" Best Online Newspaper
People with mild-to-moderate COVID-19 who were treated with a monoclonal antibody “cocktail” had lower hospitalization rates than similar people who did not receive the treatment, researchers reported on Monday in EClinicalMedicine. They looked at nearly 1,400 such patients, roughly half of whom had received Regeneron Pharmaceutical’s combination monoclonal antibody therapy. Among those who received the treatment, about 45% were older than …
Read More »REGENERON ANTIBODY THERAPY CUTS HOSPITALIZATION RATES
September 4, 2021